Erlotinib in Combination With Select Tyrosine Kinase Inhibitors in Adult Patients With Advanced Solid Tumors
Clinical trial NCT06161558 · WITHDRAWN
Trial details
- NCT number
- NCT06161558
- Sponsor
- National Cancer Institute (NCI)
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-15
- Primary completion
- 2025-07-15
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.